Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.
Identifieur interne : 000513 ( Main/Exploration ); précédent : 000512; suivant : 000514Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.
Auteurs : Achille Aouba [Oman] ; Aurelie Baldolli [France] ; Loïk Geffray [France] ; Renaud Verdon [France] ; Emmanuel Bergot [France] ; Nicolas Martin-Silva [France] ; Aurélien Justet [France]Source :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Antagoniste du récepteur à l'interleukine-1 (usage thérapeutique), Antibactériens (usage thérapeutique), Antienzymes (usage thérapeutique), Azithromycine (usage thérapeutique), Betacoronavirus (MeSH), Femelle (MeSH), Hospitalisation (MeSH), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Indice de gravité de la maladie (MeSH), Infections à coronavirus (imagerie diagnostique), Infections à coronavirus (immunologie), Infections à coronavirus (physiopathologie), Infections à coronavirus (traitement médicamenteux), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (imagerie diagnostique), Pneumopathie virale (immunologie), Pneumopathie virale (physiopathologie), Pneumopathie virale (traitement médicamenteux), Poumon (imagerie diagnostique), Protéine C-réactive (immunologie), Résultat thérapeutique (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Syndrome de détresse respiratoire de l'adulte (physiopathologie), Tomodensitométrie (MeSH), Unités de soins intensifs (MeSH), Évolution de la maladie (MeSH).
- MESH :
- imagerie diagnostique : Infections à coronavirus, Pneumopathie virale, Poumon.
- immunologie : Infections à coronavirus, Pneumopathie virale, Protéine C-réactive.
- physiopathologie : Infections à coronavirus, Pneumopathie virale, Syndrome de détresse respiratoire de l'adulte.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Antagoniste du récepteur à l'interleukine-1, Antibactériens, Antienzymes, Azithromycine, Hydroxychloroquine.
- Adulte d'âge moyen, Betacoronavirus, Femelle, Hospitalisation, Humains, Indice de gravité de la maladie, Mâle, Pandémies, Résultat thérapeutique, Sujet âgé de 80 ans ou plus, Tomodensitométrie, Unités de soins intensifs, Évolution de la maladie.
English descriptors
- KwdEn :
- Aged, 80 and over (MeSH), Anti-Bacterial Agents (therapeutic use), Azithromycin (therapeutic use), Betacoronavirus (MeSH), C-Reactive Protein (immunology), Coronavirus Infections (diagnostic imaging), Coronavirus Infections (drug therapy), Coronavirus Infections (immunology), Coronavirus Infections (physiopathology), Disease Progression (MeSH), Enzyme Inhibitors (therapeutic use), Female (MeSH), Hospitalization (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Intensive Care Units (MeSH), Interleukin 1 Receptor Antagonist Protein (therapeutic use), Lung (diagnostic imaging), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (diagnostic imaging), Pneumonia, Viral (drug therapy), Pneumonia, Viral (immunology), Pneumonia, Viral (physiopathology), Respiratory Distress Syndrome, Adult (physiopathology), Severity of Illness Index (MeSH), Tomography, X-Ray Computed (MeSH), Treatment Outcome (MeSH).
- MESH :
- chemical , immunology : C-Reactive Protein.
- chemical , therapeutic use : Anti-Bacterial Agents, Azithromycin, Enzyme Inhibitors, Hydroxychloroquine, Interleukin 1 Receptor Antagonist Protein.
- diagnostic imaging : Coronavirus Infections, Lung, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- immunology : Coronavirus Infections, Pneumonia, Viral.
- physiopathology : Coronavirus Infections, Pneumonia, Viral, Respiratory Distress Syndrome, Adult.
- Aged, 80 and over, Betacoronavirus, Disease Progression, Female, Hospitalization, Humans, Intensive Care Units, Male, Middle Aged, Pandemics, Severity of Illness Index, Tomography, X-Ray Computed, Treatment Outcome.
DOI: 10.1136/annrheumdis-2020-217706
PubMed: 32376597
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.</title>
<author><name sortKey="Aouba, Achille" sort="Aouba, Achille" uniqKey="Aouba A" first="Achille" last="Aouba">Achille Aouba</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France achille.aouba@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<wicri:noRegion>Caen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baldolli, Aurelie" sort="Baldolli, Aurelie" uniqKey="Baldolli A" first="Aurelie" last="Baldolli">Aurelie Baldolli</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Geffray, Loik" sort="Geffray, Loik" uniqKey="Geffray L" first="Loïk" last="Geffray">Loïk Geffray</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Lisieux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Verdon, Renaud" sort="Verdon, Renaud" uniqKey="Verdon R" first="Renaud" last="Verdon">Renaud Verdon</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bergot, Emmanuel" sort="Bergot, Emmanuel" uniqKey="Bergot E" first="Emmanuel" last="Bergot">Emmanuel Bergot</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martin Silva, Nicolas" sort="Martin Silva, Nicolas" uniqKey="Martin Silva N" first="Nicolas" last="Martin-Silva">Nicolas Martin-Silva</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Justet, Aurelien" sort="Justet, Aurelien" uniqKey="Justet A" first="Aurélien" last="Justet">Aurélien Justet</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32376597</idno>
<idno type="pmid">32376597</idno>
<idno type="doi">10.1136/annrheumdis-2020-217706</idno>
<idno type="wicri:Area/Main/Corpus">001420</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001420</idno>
<idno type="wicri:Area/Main/Curation">001420</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001420</idno>
<idno type="wicri:Area/Main/Exploration">001420</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.</title>
<author><name sortKey="Aouba, Achille" sort="Aouba, Achille" uniqKey="Aouba A" first="Achille" last="Aouba">Achille Aouba</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France achille.aouba@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<wicri:noRegion>Caen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baldolli, Aurelie" sort="Baldolli, Aurelie" uniqKey="Baldolli A" first="Aurelie" last="Baldolli">Aurelie Baldolli</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Geffray, Loik" sort="Geffray, Loik" uniqKey="Geffray L" first="Loïk" last="Geffray">Loïk Geffray</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Lisieux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Verdon, Renaud" sort="Verdon, Renaud" uniqKey="Verdon R" first="Renaud" last="Verdon">Renaud Verdon</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bergot, Emmanuel" sort="Bergot, Emmanuel" uniqKey="Bergot E" first="Emmanuel" last="Bergot">Emmanuel Bergot</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martin Silva, Nicolas" sort="Martin Silva, Nicolas" uniqKey="Martin Silva N" first="Nicolas" last="Martin-Silva">Nicolas Martin-Silva</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Justet, Aurelien" sort="Justet, Aurelien" uniqKey="Justet A" first="Aurélien" last="Justet">Aurélien Justet</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Pulmonology, CHU Caen, Caen, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pulmonology, CHU Caen, Caen</wicri:regionArea>
<placeName><region type="region">Région Normandie</region>
<region type="old region">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged, 80 and over (MeSH)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Azithromycin (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>C-Reactive Protein (immunology)</term>
<term>Coronavirus Infections (diagnostic imaging)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Disease Progression (MeSH)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Interleukin 1 Receptor Antagonist Protein (therapeutic use)</term>
<term>Lung (diagnostic imaging)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnostic imaging)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Respiratory Distress Syndrome, Adult (physiopathology)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Antagoniste du récepteur à l'interleukine-1 (usage thérapeutique)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Antienzymes (usage thérapeutique)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à coronavirus (imagerie diagnostique)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (physiopathologie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (imagerie diagnostique)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (physiopathologie)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Poumon (imagerie diagnostique)</term>
<term>Protéine C-réactive (immunologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Syndrome de détresse respiratoire de l'adulte (physiopathologie)</term>
<term>Tomodensitométrie (MeSH)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Évolution de la maladie (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>C-Reactive Protein</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Azithromycin</term>
<term>Enzyme Inhibitors</term>
<term>Hydroxychloroquine</term>
<term>Interleukin 1 Receptor Antagonist Protein</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Coronavirus Infections</term>
<term>Lung</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Protéine C-réactive</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagoniste du récepteur à l'interleukine-1</term>
<term>Antibactériens</term>
<term>Antienzymes</term>
<term>Azithromycine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged, 80 and over</term>
<term>Betacoronavirus</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Severity of Illness Index</term>
<term>Tomography, X-Ray Computed</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tomodensitométrie</term>
<term>Unités de soins intensifs</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32376597</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>79</Volume>
<Issue>10</Issue>
<PubDate><Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.</ArticleTitle>
<Pagination><MedlinePgn>1381-1382</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217706</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aouba</LastName>
<ForeName>Achille</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">0000-0003-1726-3811</Identifier>
<AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France achille.aouba@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baldolli</LastName>
<ForeName>Aurelie</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Geffray</LastName>
<ForeName>Loïk</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, CH Lisieux, Lisieux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Verdon</LastName>
<ForeName>Renaud</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bergot</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonology, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Martin-Silva</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine and Clinical Immunology, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Justet</LastName>
<ForeName>Aurélien</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonology, CHU Caen, Caen, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053590">Interleukin 1 Receptor Antagonist Protein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053590" MajorTopicYN="N">Interleukin 1 Receptor Antagonist Protein</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome, Adult</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">antirheumatic agents</Keyword>
<Keyword MajorTopicYN="Y">biological therapy</Keyword>
<Keyword MajorTopicYN="Y">cytokines</Keyword>
<Keyword MajorTopicYN="Y">interleukin 1 receptor antagonist protein</Keyword>
<Keyword MajorTopicYN="Y">therapeutics</Keyword>
</KeywordList>
<CoiStatement>Competing interests: AA, outside of this work, obtained non-financial support for research in giant cells arteritis with Anakinra from SOBI Phramaceutics, .</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32376597</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-217706</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-217706</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
<li>Oman</li>
</country>
<region><li>Basse-Normandie</li>
<li>Région Normandie</li>
</region>
<settlement><li>Caen</li>
<li>Lisieux</li>
</settlement>
</list>
<tree><country name="Oman"><noRegion><name sortKey="Aouba, Achille" sort="Aouba, Achille" uniqKey="Aouba A" first="Achille" last="Aouba">Achille Aouba</name>
</noRegion>
</country>
<country name="France"><region name="Région Normandie"><name sortKey="Baldolli, Aurelie" sort="Baldolli, Aurelie" uniqKey="Baldolli A" first="Aurelie" last="Baldolli">Aurelie Baldolli</name>
</region>
<name sortKey="Bergot, Emmanuel" sort="Bergot, Emmanuel" uniqKey="Bergot E" first="Emmanuel" last="Bergot">Emmanuel Bergot</name>
<name sortKey="Geffray, Loik" sort="Geffray, Loik" uniqKey="Geffray L" first="Loïk" last="Geffray">Loïk Geffray</name>
<name sortKey="Justet, Aurelien" sort="Justet, Aurelien" uniqKey="Justet A" first="Aurélien" last="Justet">Aurélien Justet</name>
<name sortKey="Martin Silva, Nicolas" sort="Martin Silva, Nicolas" uniqKey="Martin Silva N" first="Nicolas" last="Martin-Silva">Nicolas Martin-Silva</name>
<name sortKey="Verdon, Renaud" sort="Verdon, Renaud" uniqKey="Verdon R" first="Renaud" last="Verdon">Renaud Verdon</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000513 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000513 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32376597 |texte= Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32376597" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidFranceV1
This area was generated with Dilib version V0.6.37. |